Remifentanil Preconditioning Confers Cardioprotection via Cardiac κ- and δ-Opioid Receptors
- 1 February 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesiology
- Vol. 102 (2), 371-378
- https://doi.org/10.1097/00000542-200502000-00020
Abstract
Background Remifentanil preconditioning (RPC) reduces the infarct size in anesthetized rat hearts, and this effect seems to be mediated by all three types of opioid receptors (ORs). Because there is evidence of only kappa- and delta- but not mu-ORs in the rat heart, the authors investigated whether RPC confers cardioprotection via cardiac kappa- and delta-OR as well as via extracardiac mu-OR agonist activity. The authors also investigated the involvement of signaling mechanisms, namely protein kinase C and mitochondrial adenosine triphosphate-sensitive potassium (KATP) channels. Methods The hearts of male Sprague-Dawley rats weighing 190-210 g were removed, mounted on a Langendorff apparatus, and perfused retrogradely at 100 cm H2O with Krebs-Ringer's solution. All hearts were subjected to 30 min of ischemia and 2 h of reperfusion. The study consisted of three series of experiments on the effect of ischemic preconditioning or RPC (10, 50, and 100 ng/ml remifentanil) after blockade of OR subtypes (delta-OR antagonist naltrindol, kappa-OR antagonist nor-binaltorphimine, and mu-OR antagonist CTOP). The involvement of protein kinase C or the KATP channel in the cardioprotection of RPC was also investigated using specific blockers in each group. RPC was produced by three cycles of 5-min perfusion of remifentanil in Krebs-Ringer's solution interspersed with a 5-min reperfusion with Krebs solution only. Infarct size, as a percentage of the area at risk, was determined by 2,3,5-triphenyltetrazolium staining. Results Infarct size as a percentage of the area at risk was significantly reduced after RPC from 51.9 +/- 5.0% (control, n = 8) to 36.2 +/- 10.0% (100 ng/ml RPC, n = 8, P < 0.01). This effect was stopped by pretreatment with naltrindol (52.3 +/- 5.2%) and nor-binaltorphimine (43.5 +/- 6.0%) but not CTOP (37.1 +/- 6.0%). Chelerythrine and GF109203X, both protein kinase C inhibitors, abolished the effects of RPC or ischemic preconditioning on infarct size as a percentage of area at risk. 5-Hydroxydecanoate (a selective mitochondrial KATP channel blocker) also abolished the cardioprotection of RPC and IPC, but HMR-1098 (a selective inhibitor of the sarcolemmal KATP channel) did not. Conclusion Cardiac delta- and kappa- but not mu-ORs mediate the cardioprotection produced by RPC. Both protein kinase C and the mitochondrial KATP channel were involved in this effect.Keywords
This publication has 16 references indexed in Scilit:
- Cardioprotection of Interleukin-2 Is Mediated via κ-Opioid ReceptorsThe Journal of pharmacology and experimental therapeutics, 2004
- Roles of KATP channels in delayed cardioprotection and intracellular Ca2+ in the rat heart as revealed by κ‐opioid receptor stimulation with U50,488HBritish Journal of Pharmacology, 2003
- Role of Opioid δ1Receptors, Mitochondrial KATPChannels, and Protein Kinase C during Cardiocyte ApoptosisJournal of Molecular and Cellular Cardiology, 2001
- Distinct Components of Morphine Effects on Cardiac Myocytes are Mediated by the κ and δ Opioid ReceptorsJournal of Molecular and Cellular Cardiology, 1997
- Pharmacokinetics and Pharmacodynamics of RemifentanilAnesthesiology, 1997
- Doxorubicin-induced Apoptosis in Spontaneously Hypertensive Rats: Differential Effects in Heart, Kidney and Intestine, and Inhibition by ICRF-187Journal of Molecular and Cellular Cardiology, 1996
- Characterization of [3H]U69593 binding sites in the rat heart by receptor binding assaysJournal of Molecular and Cellular Cardiology, 1991
- Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart— an attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesisJournal of Molecular and Cellular Cardiology, 1990
- Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenolBiochimica et Biophysica Acta (BBA) - Biomembranes, 1989
- Opiate binding in rat hearts: Modulation of binding after hemorrhagic shockBiochemical and Biophysical Research Communications, 1985